13621-26-6

Usage

InChI:InChI=1/C12H16O2/c1-9-6-7-11(10(2)8-9)4-3-5-12(13)14/h6-8H,3-5H2,1-2H3,(H,13,14)

Upstream product

• 1057672-52-2 4-(2,4-dimethyl-phenyl)-butyronitrile 
• 7647-01-0 hydrogenchloride 
• 15880-03-2 4-(2,4-dimethylphenyl)-4-oxobutanoic acid 
• 108-38-3 m-xylene 
• 20883-81-2 4-(2,4-dimethylphenyl)-3-butenoic acid 
• 27645-10-9 1-(3-bromo-propyl)-2,4-dimethyl-benzene 
• 27650-80-2 3-(2,4-dimethylphenyl)propan-1-ol 
• 854427-17-1 4-(2,4-dimethyl-phenyl)-butyric acid amide 

Downstream Products

• 13621-25-5 5,7-dimethyltetralone 
• 113795-47-4 4-(2,4-dimethyl-phenyl)-butyryl chloride 
• 113795-44-1 4-[4-(2,4-Dimethyl-phenyl)-butyl]-phenol 
• 113795-51-0 1-[4-(4-Methoxy-phenyl)-butyl]-2,4-dimethyl-benzene 
• 113795-49-6 4-(2,4-Dimethyl-phenyl)-1-(4-methoxy-phenyl)-butan-1-one 
• 113795-42-9 1-{4-[4-(4-Bromo-butoxy)-phenyl]-butyl}-2,4-dimethyl-benzene 
• 113795-22-5 6-{4-[4-(2,4-Dimethyl-phenyl)-butyl]-phenoxy}-2,2-dimethyl-hexanoic acid 
• 53156-12-0 3,4-dihydro-1,5,7,trimethylnaphtahlene 
• 2131-39-7 1,3,5-Trimethylnaphthalene 
• 144404-70-6 ethyl α,α-(4-methyl-2-ketocyclohexane)-γ-(5',7'-dimethyl-1'-naphthyl)butanoate 
• 22565-59-9 4-(2,4-Dimethyl-cyclohexyl)-butylchlorid 

Relevant academic research and scientific papers

An Electrophilic Trifluoromethylthiolation of Silylenol Ethers and β-Naphthols with Diethylaminosulfur Trifluoride and (Trifluoromethyl)trimethylsilane

An efficient and general trifluoromethylthiolation of silylenol ethers and β-naphthols have been accomplished employing the combination of diethylaminosulfur trifluoride (DAST) and (trifluoromethyl)trimethylsilane (CF3TMS) as source of electrophilic trifluoromethylthio moiety for the synthesis of α-trifluoromethylthiolated carbonyl compounds and β-naphthols in good yields. Important features of this method include wide functional group tolerance and use of readily available DAST/CF3TMS. Potential of the methodology was demonstrated via the synthesis of α-trifluoromethylthiolated (+)-4-cholesten-3-one and naphthoquinone. (Figure presented.).

AMINO ALCOHOL COMPOUND

A pharmaceutical composition is provided that has a low toxicity, demonstrates superior physicochemical properties and pharmacokinetics, and has superior peripheral blood lymphocyte count lowering activity. The pharmaceutical composition contains a compound having general formula (I): (wherein R 1 represents a methyl group or an ethyl group, R 2 represents a methyl group or an ethyl group, and R 3 represents a phenyl group substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a lower alkyl group, a cycloalkyl group, a lower alkoxy group, a halogeno lower alkyl group, a lower aliphatic acyl group and a cyano group), a pharmacologically acceptable salt thereof or a pharmacologically acceptable ester thereof.